Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Good Shroom Co Inc V.MUSH

Alternate Symbol(s):  TGSHF

The Good Shroom Co Inc. is a Canada-based company, which is engaged in the production and sale of cannabis-based products and beverages. The Company produces beverage products under the Teonan Velada, and Nordique Royale brands. It offers a functional instant mushroom beverages under the Teonan brand; cannabis-infused functional mushroom beverages under the Velada brand; and hash products under... see more

TSXV:MUSH - Post Discussion

Good Shroom Co Inc > CLUNY CAPITAL CORP QT TEONAN BIOMEDICAL - The Good Shroom Co
View:
Post by wrightfoot2000 on Jan 13, 2021 3:36pm

CLUNY CAPITAL CORP QT TEONAN BIOMEDICAL - The Good Shroom Co

Leede Jones Gable is acting as Agent for a Subscription Receipts Units offering for Cluny Capital Corp. for its QT with Teonan Biomedical Inc. 
 Please be advised that books are now open on the above-mentioned deal.
Selling group books are open on the above-mentioned offering but may close without further notice. Please reflect your firm interest to syndication@leedejonesgable.com
 
 
All demand is subject to acceptance and/ or rejection.
 

Cluny Capital Corp. (TSXV: CLN.h)

 
Best-efforts, private placement offering of Subscription Receipt Units
 
 
Issue Size: A minimum of C$1,500,000 and up to a maximum of C$2,875,000
Price: $0.25 per Subscription Receipt Units
Selling Concession: 6% cash + 6% broker warrants (broker warrants on orders in excess of $75,000)
Eligibility: Eligible for RRSPs, RRIFs, RDSPs, RESPs, TFSAs and DPSPs
Subscription: By way of a subscription agreement – accredited investors only.
Jurisdictions: BC, Alberta, Ontario, Quebec
Use of Proceeds: Working capital for the Qualifying Transaction with Teonan Biomedical Inc.
Closing: On or about January 31, 2021
Agent: Leede Jones Gable Inc.
 
Attached:
  • Corporate Presentation
 
 
Jean-Francois Perrault
Corporate Finance / Financement corporatif
 
Leede Jones Gable Inc.
2000 Peel - Suite 710
Montreal, QC, H3A 2W5
Be the first to comment on this post